Implanet
Offers a range of surgical implants such as sutures, anchors, prosthesis, acetabular cups,and posterior fixation systems for hips, knees, spine, and arthroscopy.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €2.0m | Post IPO Debt | |
| Total Funding | 000k | ||
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (14 %) | 10 % | (19 %) | 2 % | 31 % | (7 %) | 26 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (71 %) | (38 %) | (43 %) | (71 %) | (39 %) | (74 %) | (46 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (83 %) | (49 %) | (66 %) | (75 %) | (44 %) | (90 %) | (46 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 8 % | 6 % | 10 % | 12 % | 11 % | 12 % | 7 % |
Source: Company filings or news article
Related Content
Implanet SA is a medical technology company that specializes in the design, manufacture, and sale of implants for orthopedic surgery. The company operates in two main markets: spine and knee arthroplasty. Its flagship product is the JAZZ™ platform, which includes a range of braided and sublaminar implants used in spinal fusion surgery to treat conditions like scoliosis and degenerative disc disease. Implanet also offers a range of products for knee replacement procedures.
The company controls the entire production process, with manufacturing facilities in France, ensuring a high level of quality and compliance with stringent safety standards. Implanet serves a global market, selling its products to hospitals and surgical centers through a direct sales force and a network of distributors. The business model is based on the sale of these high-value medical devices to healthcare providers.
Keywords: orthopedic implants, spinal surgery, knee arthroplasty, medical devices, JAZZ implant, surgical technology, spine fixation, medical technology, implant manufacturing, healthcare products
Tech stack
Investments by Implanet
Edit